Evaluating the effectiveness of anti-Nogo treatment in spinal cord injuries
Abstract As humans, we cannot regenerate axons within the central nervous system (CNS), therefore, making any damage to it permanent. This leads to the loss of sensory and motor function below the site of injury and can be crippling to a person’s health. Spontaneous recovery can occur from plastic c...
Main Authors: | Raihan Mohammed, Kaesi Opara, Rahul Lall, Utkarsh Ojha, Jinpo Xiang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | Neural Development |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13064-020-0138-9 |
Similar Items
-
MAG, myelin and overcoming growth inhibition in the CNS.
by: Lisa eMcKerracher, et al.
Published: (2015-09-01) -
Can We Design a Nogo Receptor-Dependent Cellular Therapy to Target MS?
by: Min Joung Kim, et al.
Published: (2018-12-01) -
Nogo receptor expression in microglia/macrophages during experimental autoimmune encephalomyelitis progression
by: Amani A Alrehaili, et al.
Published: (2018-01-01) -
That’s a Wrap! Molecular Drivers Governing Neuronal Nogo Receptor-Dependent Myelin Plasticity and Integrity
by: Steven Petratos, et al.
Published: (2020-08-01) -
Nogo receptor is involved in the adhesion of dendritic cells to myelin
by: Martin Roland, et al.
Published: (2011-09-01)